A new syndrome affecting women has been identified by doctors; the sexual condition tentatively named ‘Persistent Sexual Arousal Syndrome’, (PSAS), has as its primary symptom continual unrelieved feelings of genital arousal in the absence of genuine sexual interest or desire.

According to researchers David Goldmeier and Sandra Leiblum, PSAS in women has been unrecognised until now and exists when a woman becomes involuntarily aroused for extended periods of time in the absence of sexual desire.

Goldmeier says such genital arousal is highly distressing as it is unprovoked and unrelieved by orgasm.

The study says it is unclear what the causes of PSAS are although a link to antidepressants has not been dismissed.

Clinical observations of the condition have found evidence of engorgement and oedema of the labia, vulva and clitoris.

Dr Goldmeier says it is hard to gauge how prevalent the condition is as women are reluctant to come forward for help.

He says many women are too embarrassed to talk about the symptoms and those that have come forward have reported a high degree of distress and even at times thoughts of suicide.

Dr Leiblum says a recent internet survey suggests women with PSAS come from a range of backgrounds and age groups and much is unknown about the syndrome.

Leiblum says the condition warrants further research not only because it is such a distressing and perplexing condition, but also because understanding its aetiology and treatment may lead to greater understanding of other aspects of female sexual response.

At present there is no specific therapy to treat PSAS, says Dr Goldmeier who has been working with affected women in the UK, although electroconvulsive therapy (ECT) has resulted in clinical improvement in cases where there was severe depression associated with the syndrome.

He believes it is critical that awareness is raised of PSAS amongst clinicians and the general population, and that women should not feel marginalised by the condition.

He urges women with PSAS to seek assistance.

The research is published in the April issue (Vol. 17) of the International Journal of STD and AIDS.